References
1. Domenico Santoro and Rosanna Marsella. Animal Models of Allergic Diseases. Vet. Sci. 2014; 1:192-212.
2. Arif, A. A., Whitehead, L. W., Delclos, G. L., Tortolero, S. R., Lee, E. S. Prevalence and risk factors of work related asthma by industry among United States workers: data from the third national health and nutrition examination survey (1988-94), Occup. Environ. Med. 2002; 59:505-511.
3. Busse, W. W., Lemanske, R. F. Advances in immunology - Asthma, N. Engl. J. Med. 2001; 344:350-362.
4. Finkelman, F. D., Rothenberg, M. E., Brandt, E. B., Morris, S. C., Strait, R. T. Molecular mechanisms of anaphylaxis: lessons from studies with murine models, J. Allergy Clin. Immunol. 2005; 115:449-457.
5. Robert K. Bush and Gregg M. Stave. Laboratory Animal Allergy: An Update. ILAR Journal 2003; 44(1):28-51
6. Sorrell AH, Gottesman J. Mouse allergy-A case report. Ann Allergy 1957; 15:662-663.
7. Pauluhn, J., Mohr, U. Experimental approaches to evaluate respiratory allergy in animal models, Exp. Toxicol. Pathol. 2005; 56:203-234.
8. Patel K. N, Chorawala M. R. ANIMAL MODELS OF ASTHMA. Journal of Pharmaceutical Research And Opinion 2011; 1(5):139-147.
9. David G. Chapman, Jane E. Tully, James D. Nolin, Yvonne M Jansen-Heininger and Charles G. Irvin. Animal Models of Allergic Airways Disease: Where Are We and Where to Next? J Cell Biochem. 2014; 115(12): 2055–2064
10. Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma. 2009;46:73-80.
11. Seyyede Masoume Athari, Faride Afshari, Asie Eftekhari, Seyyed Shamsadin Athari. The surveillance system, diagnosis and treatment challenges of asthma and health policy orientation of main challenges. J Pain Manage Ther. 2017; 1(2):1-5
12. Al-Rawas OA, Al-Riyami BM, Al-Kindy H, et al. Regional variation in the prevalence of asthma symptoms among Omani school children: Comparisons from two nationwide cross-sectional surveys six years apart. Sultan Qaboos University Med J. 2008; 8:157-64.
13. Seyyed Shamsadin Athari, Zahra Pourpak, Gert Folkerts, Johan Garssen, Mostafa Moin, Ian M. Adcock, Masoud Movassaghi, Mehdi Shafiee Ardestani, Seyed Mohammad Moazzeni, Esmaeil Mortaz. Conjugated Alpha-Alumina nanoparticle with vasoactive intestinal peptide as a Nano-drug in treatment of allergic asthma in mice. European Journal of Pharmacology 2016; 791:811–820
14. Kumar, R. K., Foster, P. S. Modeling allergic asthma in mice: pitfalls and opportunities, Am. J. Respir. Cell Mol. Biol. 2002; 27:267-272.
15. Arts, J. H. E., Kuper, C. F. Animal models to test respiratory allergy of low molecular weight chemicals: A guidance, Methods. 2007; 41:61-71.
16. Sakai, K., Yokoyama, A., Kohno, N., Hiwada, K. Effect of different sensitizing doses of antigen in a murine model of atopic asthma, Clin. Exp. Immunol. 1999; 118:9-15.
17. Lee SY, Kim JS, Lee JM, Kwon SS, Kim KH, Moon HS et al. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm. Pharmacol. Ther 2008; 21:14–9.
18. Bates JH, Wagers SS, Norton RJ, Rinaldi LM, Irvin CG. Exaggerated airway narrowing in mice treated with intratracheal cationic protein. J Appl Physiol (1985). 2006; 100(2):500–6.
19. Martin JG, Campbell HR, Iijima H, Gautrin D, Malo JL, Eidelman DH, Hamid Q, Maghni K. Chlorine-induced injury to the airways in mice. Am J Respir Crit Care Med. 2003; 168(5):568–74.
20. Stacy J. Park, Maria T. Wiekowski, Sergio A. Lira and Borna Mehrad. Neutrophils Regulate Airway Responses in a Model of Fungal Allergic Airways Disease. J Immunol 2006; 176:2538-2545
21. Templeton SP, Buskirk AD, Green BJ, Beezhold DH, Schmechel D. Murine models of airway fungal exposure and allergic sensitization. Medical Mycology March 2010; 48:217–228
22. Hogaboam, C. M., K. Blease, B. Mehrad, M. L. Steinhauser, T. J. Standiford, S. L. Kunkel, and N. W. Lukac. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol. 2000; 156: 723–732.
23. Blease, K., B. Mehrad, T. J. Standiford, N. W. Lukacs, J. Gosling, L. Boring, I. F. Charo, S. L. Kunkel, and C. M. Hogaboam. Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice. J. Immunol. 2000; 165: 2603–2611.
24. Blease, K., B. Mehrad, T. J. Standiford, N. W. Lukacs, S. L. Kunkel, S. W. Chensue, B. Lu, C. J. Gerard, and C. M. Hogaboam. Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J. Immunol. 2000; 165: 1564–1572.
25. Tournoy KG, Kips JC, Schou C, Pauwels RA. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin. Exp. Allergy 2000; 30:79–85.
26. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodelling. Am. J. Respir. Crit. Care Med 2004; 169:378–85.
27. I M. Helm. Food Allergy Animal Models An Overview. Ann. N.Y. Acad. Sci. 2002; 964: 139–150.
28. Helm, R.M. Food allergy animal models: An overview. Ann. N. Y. Acad. Sci. 2002; 964:139–150.
29. Helm, R.M.; Burks, Q.W. Animal models of food allergy. Curr. Opin. Allergy Clin. Immunol. 2002; 2:541–546.
30. Dearman, R.J.; Stone, S.; Caddick, H.T.; Basketter, D.A.; Kimber, I. Evaluation of protein allergenic potential in mice: Dose-response analyses. Clin. Exp. Allergy. 2003; 33:1586-1594.
31. Li, X.M.; Schofield, B.H.; Huang, C.K.; Kleiner, G.I.; Sampson, H.A. A murine model of IgE-mediated cow’s milk hypersensitivity. J. Allergy Clin. Immunol. 1999; 103:206-214.
32. Katrine Lindholm Bogh, Jolanda van Bilsen, Robert Glogowski, Ivan Lopez‑Exposito, Gregory Bouchaud, Carine Blanchard, Marie Bodinier, Joost Smit, Raymond Pieters, Shanna Bastiaan‑Net, Nicole de Wit, Eva Untersmayr, Karine Adel‑Patient, Leon Knippels, Michelle M. Epstein, Mario Noti, Unni Cecilie Nygaard, Ian Kimber, Kitty Verhoeckx and Liam O’Mahony. Current challenges facing the assessment of the allergenic capacity of food allergens in animal models. lin Transl Allergy 2016; 6:21
33. Jin H, He R, Oyoshi M, Geha R. Animal models of atopic dermatitis. J Invest Dermatol. 2009; 129: 31-40.
34. Lee KS, Jeong ES, Heo SH, Seo JH, Jeong DG, Choi YK. A novel model for human atopic dermatitis: Application of repeated DNCB patch in BALB/c mice, in comparison with NC/Nga mice. Lab Anim Res. 2010: 26: 95-102.
35. Finkelman FD. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol. 2007; 120(3):506-15.
36. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002; 109:658-68.
37. Ishizaka T, Conrad DH. Binding characteristics of human IgE receptors and initial triggering events in human mast cells for histamine release. Monogr Allergy 1983; 18:14-24.
38. Wastling JM, Knight P, Ure J, Wright S, Thornton EM, Scudamore CL, et al. Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the beta-chymase, mouse mast cell protease-1. Am J Pathol 1998; 153:491-504.
39. Ha TY, Reed ND, Crowle PK. Immune response potential of mast celld eficient W/Wv mice. Int Arch Allergy Appl Immunol 1986; 80:85-90.
40. Martin TR, Ando A, Takeishi T, Katona I, Drazen J, Galli S. Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice. J Immunol 1993; 151:367-76.
41. Weiler JM. Anaphylaxis in the general population: a frequent and occasionally fatal disorder that is underrecognized. J Allergy Clin Immunol 1999; 104:271-3.
42. Lazar G Jr, Lazar G, Kaszaki J, Olah J, Kiss I, Husztik E. Inhibition of anaphylactic shock by gadolinium chloride-induced Kupffer cell blockade. gents Actions 1994; 41:C97-8.
43. Li XM, Serebrisky D, Lee SY, Huang CK, Bardina L, Schofield BH, et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 2000; 106:150-8.
44. Brandt EB, Strait RT, Hershko D, Wang Q, Muntel EE, Scribner TA, et al. Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 2003; 112:1666-77.
45. Birmingham NP, Parvataneni S, Hassan HM, Harkema J, Samineni S, Navuluri L, et al. An adjuvant-free mouse model of tree nut allergy using hazelnut as a model tree nut. Int Arch Allergy Immunol 2007; 144:203-10.
46. Danko G, Sherwood JE, Grissom B, Kreutner W, Chapman RW. Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis. Pharmacol Res Commun 1988; 20:785-98.
47. Duschl A, Muller T, Sebald W. Antagonistic mutant proteins of interleukin-4. Behring Inst Mitt 1995; 87-94.
48. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A. A novel human immunoglobulin Fcg Fce bifunctional fusion protein inhibits FceRI-mediated degranulation. Nat Med 2002; 8:518-21.
49. Bachelet I, Munitz A, Levi-Schaffer F. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol 2006; 117:1314-20.
50. Nash SD, Steele PH, Kamilaris JS, Pons L, Kulis M, Lee LA, et al. Oral peanut immunotherapy for peanut allergic patients. J Allergy Clin Immunol 2007; 119(suppl):S158.
51. Bonini S & Ghinelli E. The early and late phase of the ocular allergic reaction. Acta Ophthalmol Scand 2000; 78(1): 41.
52. Romagnani S, Maggi E, Parronchi P, Macchia D, Piccinni MP & Ricci M. Increased numbers of Th2-like CD4 + T cells in target organs and in the allergenspecific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells. Int Arch Allergy Appl Immunol 1991; 94:133-136.
53. Calonge M. Classification of ocular atopic ⁄ allergic disorders and conditions: an unsolved problem. Acta Ophthalmol Scand 1999; 77:10-13.
54. Pedro Giavina-Bianchi, Jorge Kalil and Luiz Vicente Rizzo. Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response. Acta Ophthalmol. 2008: 86: 670–675
55. Ballas Z, Blumenthal M, Tinkelman DG, Kriz R & Rupp G. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993; 38:141-148.
56. D. A. Groneberg, L. Bielory, A. Fischer, S. Bonini, U. Wahn. Animal models of allergic and inflammatory conjunctivitis. Allergy 2003: 58: 1101–1113
57. Merayo-Lloves J, Zhao TZ, Dutt JE, Foster CS. A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium. J Allergy Clin Immunol 1996; 97:1129–1140.
58. Izushi K, Nakahara H, Tai N, Mio M, Watanabe T, Kamei C. The role of histamine H(1)receptors in late-phase reaction of allergic conjunctivitis. Eur J Pharmacol 2002; 440:79–82.
59. McCusker, C. T. Use of mouse models of allergic rhinitis to study the upper and lower airway link, Curr. Opin. Allergy Clin. Immunol. 2004; 4:11-16.
60. Pauluhn, J., Mohr, U. Experimental approaches to evaluate respiratory allergy in animal models, Exp. Toxicol. Pathol. 2005; 56:203-234.
61. Sun R, Tang X, Yao H, Hong S, Yang Y, Kou W, Wei P. Establishment of a new animal model of allergic rhinitis with biphasic sneezing by intranasal sensitization with Staphylococcal enterotoxin B. Exp Ther Med. 2015; 10(2):407-412.
62. Zhao Zhu, Hongran F. Stone, Thai Q.D. Thach, B.S., Luke Garcia, and Curtis L. Ruegg. A novel botulinum neurotoxin topical gel: Treatment of allergic rhinitis in rats and comparative safety profile. American Journal of Rhinology & Allergy 2012; 26(6):450-4
63. Herz, U., Renz, H., Wiedermann, U. Animal models of type I allergy using recombinant allergens, Methods. 2004; 32:271-280.
64. Yoshiyuki Nakano, Yujiro Kidani, Kumiko Goto, Shingo Furue, Yasuhiko Tomita, Naoki Inagaki, Hiroyuki Tanaka and Michitaka Shichijo. Role of Prostaglandin D2 and DP1 Receptor on Japanese Cedar Pollen-Induced Allergic Rhinitis in Mice. J Pharmacol Exp Ther 2016; 357:258–263.
65. McCusker C, Chicoine M, Hamid Q, and Mazer B. Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airways disease. J Allergy Clin Immunol 2002; 110:891–898.
66. Nakaya M, Dohi M, Okunishi K, Nakagome K, Tanaka R, ImamuraM, Baba S, Takeuchi N, Yamamoto K, and Kaga K. Noninvasive system for evaluating allergeninduced nasal hypersensitivity in murine allergic rhinitis. Lab Invest 2006; 86:917–926.
67. Southam, D. S., Ellis, R., Wattie, J., Inman, M. D. Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice, J. Allergy Clin. Immunol. 2007; 119:848-854.